Literature DB >> 7684604

The standardization of estrogen receptors.

J A Chapman1, B G Mobbs, W M Hanna, C A Sawka, K I Pritchard, H L Lickley, M E Trudeau, E D Ryan, T C Ooi, D J Sutherland.   

Abstract

Tumour estrogen receptor (ER) status may determine the medical treatment of a patient with breast cancer; yet inter-laboratory results can vary markedly, particularly when absolute cut-offs in fmol/mg cytosol protein are used. The use of standardized log units is proposed to permit greater inter-laboratory comparability. We have assessed the biochemical ER values using the dextran-coated charcoal method with three data sets, two quality control (QC) sets for Ontario laboratories and a data set with values for 184 primary breast cancer patients seen at Women's College Hospital (WCH) between 1985 and 1986. The distributions for all the raw data were skewed toward the lower end of the range; a log transformation improved the symmetry of the distributions. There was marked inter-laboratory variation in the QC data, and standardized log units greatly reduced this variability. The WCH data had similar differentiation by tumour size and nodal status with both the raw data and standardized log units. However, standardized log units provided more consistent evidence of an association between ER and immunohistochemical ERICA. The standardized log units provide quantitative receptor values suitable for multi-centre research, for future work with clinical outcomes, and for the daily management of patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684604     DOI: 10.1016/0960-0760(93)90005-h

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  3 in total

1.  Factors associated with local breast cancer recurrence after lumpectomy alone.

Authors:  D R McCready; W Hanna; H Kahn; J A Chapman; J Wall; E B Fish; H L Lickley
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344

2.  Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study.

Authors:  C Allemani; M Sant; F Berrino; T Aareleid; G Chaplain; J W Coebergh; M Colonna; P Contiero; A Danzon; M Federico; L Gafà; P Grosclaude; G Hédelin; J Macè-Lesech; C M Garcia; E Paci; N Raverdy; B Tretarre; E M I Williams
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

3.  Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort.

Authors:  Judith-Anne W Chapman; Torsten O Nielsen; Matthew J Ellis; Phillip Bernard; Stephen Chia; Karen A Gelmon; Kathleen I Pritchard; Aurelie Le Maitre; Paul E Goss; Samuel Leung; Lois E Shepherd; Vivien H C Bramwell
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.